Correction: Breast cancer heterogeneity and its implication in personalized precision therapy

Correction: Breast cancer heterogeneity and its implication in personalized precision therapy

Bibliographic Details
Main Authors:	Liantao Guo, Deguang Kong, Jianhua Liu, Ling Zhan, Lan Luo, Weijie Zheng, Qingyuan Zheng, Chuang Chen, Shengrong Sun
Format:	Article
Language:	English
Published:	BMC 2024-01-01
Series:	Experimental Hematology & Oncology
Online Access:	https://doi.org/10.1186/s40164-024-00472-z

Similar Items

Breast cancer heterogeneity and its implication in personalized precision therapy
by: Liantao Guo, et al.
Published: (2023-01-01)

Based on whole-exome sequencing to explore the rule of Herceptin and TKI resistance in breast cancer patients
by: Liantao Guo, et al.
Published: (2024-01-01)

SIX1 amplification modulates stemness and tumorigenesis in breast cancer
by: Liantao Guo, et al.
Published: (2023-11-01)

Intraductal chemotherapy for triple-negative breast cancer: a pathway to minimally invasive clinical treatment
by: Xinhong Wu, et al.
Published: (2025-02-01)

MyD88 signaling pathways: role in breast cancer
by: Hongmei Zheng, et al.
Published: (2024-01-01)

Metabolomics reveals intratumor heterogeneity – Implications for precision medicine
by: Xiaojing Liu, et al.
Published: (2017-05-01)

Reconstruction of cancer marker analysis with holistic anatomical precision implicates heterogeneity development during breast tumor progression
by: Zhicheng Ge, et al.
Published: (2024-10-01)

T-cell priming transcriptomic markers: implications of immunome heterogeneity for precision immunotherapy
by: Hirotaka Miyashita, et al.
Published: (2023-08-01)

Personalized Management of Breast Cancer, In the Era of Precision Medicine
by: Saira Saleem
Published: (2023-02-01)

Heterogeneity of anoikis in triple-negative breast cancer subtyping and therapeutic implications
by: Kun Fang, et al.
Published: (2025-01-01)

Single-cell technologies for dissecting heterogeneity in oral tumours: Implications for precision therapy
by: Sundaram Vickram, et al.
Published: (2024-06-01)

Heterogeneity in precision oncology
by: Bartłomiej Tomasik, et al.
Published: (2024-01-01)

Editorial: Heterogeneity in breast cancer: clinical and therapeutic implications
by: Francesca Carlino, et al.
Published: (2024-02-01)

Precision medicine and personalized breast cancer: combination pertuzumab therapy
by: Reynolds K, et al.
Published: (2014-03-01)

Heterogeneity of Tumors in Breast Cancer: Implications and Prospects for Prognosis and Therapeutics
by: Nigatu Tuasha, et al.
Published: (2020-01-01)

The impact of race and ethnicity in breast cancer—disparities and implications for precision oncology
by: Kelly A. Hirko, et al.
Published: (2022-02-01)

Dosimetric Study of Tissue Heterogeneity Correction for Breast Conformal Radiotherapy
by: Dina Sinousy, et al.
Published: (2019-03-01)

Deciphering Aging, Genetic, and Epigenetic Heterogeneity in Cancer Evolution: Toward Personalized Precision Preventative Medicine
by: Lamis Naddaf, et al.
Published: (2025-03-01)

Delineating intra-tumoral heterogeneity and tumor evolution in breast cancer using precision-based approaches
by: Kutlwano Rekgopetswe Xulu, et al.
Published: (2023-08-01)

Molecular features and clinical implications of the heterogeneity in Chinese patients with HER2-low breast cancer
by: Lei-Jie Dai, et al.
Published: (2023-08-01)

Personality disorder not otherwise specified heterogeneity and its implication in psychiatric residential treatment
by: L. Bailo, et al.
Published: (2021-04-01)

Correction: Bispecifc aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies
by: Simona Camorani, et al.
Published: (2024-08-01)

Genetic Diversity Landscape in African Population: A Review of Implications for Personalized and Precision Medicine
by: Sibomana O
Published: (2024-11-01)

Breast cancer organoids and their applications for precision cancer immunotherapy
by: Dandan Guan, et al.
Published: (2023-10-01)

Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications
by: Karama Asleh, et al.
Published: (2022-09-01)

Correction: Personalized Precision Medicine for Health Care Professionals: Development of a Competency Framework
by: Fernando Martin-Sanchez, et al.
Published: (2023-02-01)

Molecular profiling of male breast cancer by multigene panel testing: Implications for precision oncology
by: Virginia Valentini, et al.
Published: (2023-01-01)

Heterogeneity in individual beliefs and its implication for valuing willingness to pay
by: Zheng Li, et al.
Published: (2021-03-01)

Deep analysis of skin molecular heterogeneities and their significance on the precise treatment of patients with psoriasis
by: Shengxiao Zhang, et al.
Published: (2024-03-01)

Root allocation and foraging precision in heterogeneous soils
by: Tara K. Rajaniemi
Published: (2022-05-01)

Publisher Correction: Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy
by: Jennifer L. Caswell-Jin, et al.
Published: (2019-05-01)

Precision and personalized medicine: What their current definition says and silences about the model of health they promote. Implication for the development of personalized health
by: Cyrille Delpierre, et al.
Published: (2023-02-01)

Towards precision radiation oncology: endocrine therapy response as a biomarker for personalization of breast radiotherapy
by: S. M. Nashir Udden, et al.
Published: (2023-01-01)

Non-genetic heterogeneity and immune subtyping in breast cancer: Implications for immunotherapy and targeted therapeutics
by: Mudassir Hassan, et al.
Published: (2024-09-01)

FROM PERSONALIZED TO PRECISION MEDICINE
by: K. V. Raskina, et al.
Published: (2017-03-01)

The Distinct Pattern of Granulomatous Lobular Mastitis with Erythema Nodosum: More Severe Conditions and Extensive Lesions
by: Bilian Zheng, et al.
Published: (2023-09-01)

Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patients
by: Courtney T. van Geelen, et al.
Published: (2022-07-01)

Correction: Amplification in Breast Cancer by Optimized RNase FISH: Frequent but Low-Level and Heterogeneous.
by: Cathy B. Moelans, et al.
Published: (2014-01-01)

A precise molecular subtyping of ulcerative colitis reveals the immune heterogeneity and predicts clinical drug responses
by: Shaocong Mo, et al.
Published: (2023-07-01)

Restoring the missing person to personalized medicine and precision psychiatry
by: Ana Gómez-Carrillo, et al.
Published: (2023-02-01)